Sit in a room with a group paperboard carton manufacturers and they'll let you know in no uncertain terms that the paperboard carton is nothing short of remarkable. The mere fact that it performs as well as it does in today's competitive world of packaging options is a testament to high technology, engineering and design innovation.

» more

MERCK'S reputation as a monster stock is at stake. Its price has tumbled 28% from its peak in late 2000, a stunning setback for shareholders of the world's second-biggest pharmaceuticals maker.In part, this is payback for Merck's laughing off the early stages of the 2000-01 bear market. Its shares soared 40% in the final nine months of

» more

An FDA advisory committee has voted overwhelmingly to recommend over-the-counter status for Claritin, Allegra, and Zyrtec, three popular prescription allergy drugs. But the drugs' manufacturers are opposing a switch, fearing that it could hurt their profits. As over-the-counter remedies, the drugs would no longer be covered by prescription plans; consumers would actually care how

» more

Even as other sectors of the domestic converting marketplace have continued to dwindle, the U.S. pharmaceutical market has remained relatively stable with its high demand for paperboard products and its respectable profit margins. Considering that a majority of Americans take at least one prescription drug each month, the numbers should not come as a surprise.

» more